Ultimate One Women Active
Natural health product licensed in Canada
- Licence holder
- Lifeagen Biosciences of Florida, Inc. dba Nu-Life North America
- NPN or DIN-HM
- 80030202
- Status
- Active licence
- Licence date
- 5 March 2012
- Revision date
- 22 October 2024
- Form
- Caplet
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chrome Source : Citrate de chrome | 180 mcg | Not calculated |
| Zinc Source : Diglycinate de zinc | 2.5 mg | Not calculated |
| Magnésium Source : Bisglycinate de magnésium | 2 mg | Not calculated |
| Chrome Source : Chromium bisglycinate | 10 mcg | Not calculated |
| Eleutherococcus senticosus Source : Racine | 15 mg | Not calculated |
| Vitex agnus-castus Source : Fruit extract Extraction ratio : 5:1 Dry plant equivalent : 25 mg | 5 mg | Not calculated |
| Vitamine C Source : Ascorbate de calcium | 25 mg | Not calculated |
| Ginkgo biloba Source : Extrait de Feuille Extraction ratio : 50:1 Dry plant equivalent : 500 mg | 10 mg | Not calculated |
| Acide pantothénique Source : DL-pantothénate de calcium | 35 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 125 mg | Not calculated |
| Zinc Source : Citrate de zinc | 10 mg | Not calculated |
| Bioflavonoïdes Source : Citrus limon - Pelure (fruit) | 50 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 59 mg | Not calculated |
| Calcium Source : Malate de calcium | 5 mg | Not calculated |
| Manganèse Source : Diglycinate de manganèse | 1 mg | Not calculated |
| Manganèse Source : Citrate de manganèse | 4 mg | Not calculated |
| Vanadium Source : Citrate de vanadium | 50 mcg | Not calculated |
| Methionine Source : DL-méthionine | 15 mg | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 400 UI | 10 mcg | Not calculated |
| Niacine Source : Acide nicotinique | 30 mg | Not calculated |
| Folate Source : Folate | 1,000 mcg | Not calculated |
| Magnésium Source : Malate de magnésium | 2 mg | Not calculated |
| Camellia sinensis Source : Extrait de Feuille Extraction ratio : 35:1 Dry plant equivalent : 350 mg | 10 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Croscarmellose de sodium, cellulose, Pharmaceutical Glaze, Silice, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | maximum: 1 Caplet | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
As a vitamin and mineral supplement with other factors to maintain good health in active women.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80030202
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging